Johnson & Johnson (NYSE:JNJ) announced today that it received FDA approval for its dual-energy ThermoCool SmartTouch SF ...
Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) approved the Dual Energy THERMOCOOL SMARTTOUCH SF Platform (DE STSF), an integrated catheter ablation ...
Johnson & Johnson advances cardiac ablation technology in Europe with availability of Dual Energy THERMOCOOL SMARTTOUCH SF ...
At close: 28 June at 6:07:38 pm GMT-4 ...
J&J launches new dual energy catheter ablation solution in Europe: Irvine, California Johnson & Johnson announced the commercial launch of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results